The White Fibrous Clots Enigma: Conspiracy or Ignored Crisis? By Chris Knight (Florida)

At the 2025 Tennessee Funeral Directors Association (TFDA) Convention in Franklin, Tennessee, a chilling revelation emerged: 64% of embalmers reported observing unusual white fibrous clots in 17% of corpses during the first half of 2025, a phenomenon they claim was unseen before the Covid-19 era. Spearheaded by retired U.S. Air Force Major Tom Haviland and Laura Kasner, these findings, supported by video evidence of embalmers raising their hands to confirm sightings, have ignited a firestorm of debate. Mainstream medicine and health authorities dismiss these claims, attributing the clots to routine post-mortem phenomena, while embalmers and independent researchers assert a link to Covid-19 mRNA vaccines or SARS-CoV-2 infections. This discrepancy poses a philosophical question: Are funeral directors collectively mistaken, or is something more sinister being ignored? I will look at the possibility of a suppressed medical crisis, delving into the evidence, the mainstream's silence, and the conspiratorial undertones of a potential cover-up.

Since 2021, embalmers worldwide have reported encountering unusual white, rubbery, fibrous clots in deceased individuals, distinct from typical post-mortem clots. At the TFDA Convention on June 8, 2025, Haviland's survey of 28 embalmers revealed that 64% observed these clots in 17% of corpses, with 70% noting micro-clotting ("coffee grounds" or "dirty blood") in a similar percentage. Disturbingly, 39% reported a 14% rise in infant deaths compared to pre-2020 levels, with some clots found in children born to vaccinated mothers. These findings build on Haviland's 2024 Worldwide Embalmer Blood Clot Survey, where 83% of 301 embalmers across multiple countries reported seeing these clots in 27.5% of bodies, up from 73% in 2023.

Biochemical analyses, led by experts like Dr. Kevin McCairn, suggest these clots are amyloidogenic fibrin aggregates, abnormal, protease-resistant protein structures with a dense, rubbery morphology. Tests using Thioflavin T staining, electron microscopy, and RT-QuIC (real-time quaking-induced conversion) indicate amyloid characteristics, potentially linked to spike protein exposure from mRNA vaccines or SARS-CoV-2 infection. High phosphorus levels (up to 4,900 ppm) and abnormal fibrinogen ratios distinguish these clots from typical thrombi, raising concerns about a novel pathological process. Reports of clots in living patients, pulled during catheterisation, and in children exposed to vaccines in utero further amplify the alarm.

Mainstream medical authorities, such as Thailand's National Vaccine Institute and haematologists like David Smadja, argue these clots are not new but are standard post-mortem fibrin aggregations, unrelated to mRNA vaccines. A 2021 Lancet study found that Covid-19 infection, not vaccination, significantly increases clotting risks, with no evidence linking mRNA vaccines to thrombosis beyond rare cases with adenoviral vaccines (e.g., AstraZeneca). Critics note that embalmers lack access to vaccination status on death certificates, undermining claims of a vaccine-clot link. The silence from institutions like the CDC and FDA, coupled with their history of rapid response to smaller-scale issues (e.g., HIV in the 1980s), fuels suspicion that these clots are being deliberately ignored.

The mainstream narrative insists that embalmers' observations are anecdotal, lacking the rigour of controlled studies. Yet, the absence of large-scale autopsies or clot screenings using specialised techniques like Thioflavin T fluorescence, required to detect amyloid structures, suggests a lack of effort to investigate. This inaction contrasts with the urgency surrounding other public health crises, raising questions about institutional priorities.

The divide between embalmers' testimonies and mainstream dismissal presents a philosophical conundrum: Are hundreds of funeral directors across multiple countries mistaken, or is a larger issue being suppressed? From a first-principles perspective, the embalmers' consistency, spanning the U.S., UK, and beyond, lends credibility to their observations. These professionals, with decades of experience, insist the clots are unprecedented, appearing only after 2021, coinciding with mRNA vaccine rollouts. The biochemical evidence, though preliminary, points to a novel pathology involving amyloid fibrils, potentially triggered by spike protein interactions, which aligns with studies linking SARS-CoV-2 to fibrinolytic abnormalities.

On the other hand, mainstream medicine's scepticism is grounded in the absence of peer-reviewed, large-scale studies confirming a vaccine-clot link. Embalmers are not medical researchers, and their surveys, while compelling, lack the controls needed to establish causation. Yet, the refusal to investigate, despite widespread reports and video evidence, suggests either bureaucratic inertia or deliberate avoidance. The philosophical question hinges on Occam's Razor: Is it more likely that embalmers are misinterpreting a natural phenomenon, or that institutions are sidestepping a politically inconvenient truth?

The conspiratorial lens posits that the silence from health authorities reflects a cover-up to protect the mRNA vaccine program, a cornerstone of global Covid-19 response. The vaccine industry, worth billions, and governments that mandated shots, face potential liability if linked to a systemic clotting issue. The rapid dismissal of embalmers' claims, without robust counter-studies, mirrors historical cases where public health crises, such as Vioxx or thalidomide, were downplayed until undeniable evidence forced action. The lack of transparency, coupled with Big Tech's censorship of clot-related discussions on platforms like X, fuels speculation of a coordinated effort to suppress inquiry.

Adding to the intrigue, some researchers suggest these clots may have prion-like properties, capable of inducing protein misfolding in a chain reaction, potentially explaining their persistence and prevalence. Reports of magnetism in vaccinated individuals, possibly linked to spike-induced iron metabolism disruption, further amplify concerns about novel vaccine effects. While these claims remain speculative, the absence of institutional rebuttals leaves room for distrust. If true, the implications are staggering: a systemic, vaccine-induced pathology affecting millions, ignored to maintain public confidence in vaccination campaigns.

The alternative explanation is that embalmers are misinterpreting a known phenomenon. Post-mortem clots, particularly fibrin-rich "chicken fat" clots, are common and could be mistaken for amyloid aggregates. Variations in embalming techniques or increased scrutiny post-Covid could amplify perceptions of novelty. The rise in infant deaths and clots in younger individuals might reflect broader trends, such as increased cardiovascular strain from SARS-CoV-2 infections, not vaccines. The lack of vaccination status data weakens causal claims, and confirmation bias among vaccine sceptics could exaggerate the issue.

However, this explanation struggles to account for the clots' unique characteristics, rubbery, protease-resistant, and amyloid-like, confirmed by independent analyses. The temporal correlation with vaccine rollouts, the global consistency of embalmer reports, and the absence of similar clots pre-2021 challenge the notion of a simple misinterpretation. The mainstream's failure to engage with these findings, beyond blanket denials, undermines its credibility.

The white fibrous clots saga is more than a medical mystery; it's a test of public health integrity. If embalmers are correct, millions may be at risk from an unaddressed pathology, with implications for vaccine policy, healthcare systems, and public trust. The reported 14% rise in infant deaths and clots in young adults (36–50 years) are particularly alarming, suggesting a generational impact. Conversely, if the clots are benign or unrelated to vaccines, dismissing embalmers' concerns without investigation risks further eroding trust in institutions already strained by Covid-19 controversies.

The philosophical tension, between trusting grassroots observations and demanding rigorous evidence, mirrors broader societal divides. The embalmers' courage in speaking out, as evidenced by TFDA President Taylor Moore's invitation to Haviland, contrasts with the silence of vascular surgeons, cardiologists, and public health agencies. This disparity suggests a systemic reluctance to confront inconvenient data, reminiscent of past public health failures.

The white fibrous clots reported by embalmers are not a hoax, as video evidence and consistent global surveys demonstrate. Whether they stem from mRNA vaccines, SARS-CoV-2, or another factor remains unproven, but the biochemical evidence, amyloidogenic fibrin aggregates linked to spike protein, demands urgent investigation. Mainstream medicine's dismissal, without robust counter-studies, fuels suspicion of a cover-up driven by political or economic motives. The philosophical question — are funeral directors wrong, or is something bigger at play? — leans toward the latter when weighing the evidence. The clots' prevalence, unique properties, and temporal link to 2021 suggest a crisis that cannot be ignored. Public health agencies must act, conducting large-scale autopsies and amyloid screenings, or risk perpetuating a tragedy that could redefine trust in medicine for generations.

https://www.thefocalpoints.com/p/breaking-tennessee-funeral-directors